Emerging role and therapeutic application of exosome in hepatitis virus infection and associated diseases
Open Access
- 4 March 2021
- journal article
- review article
- Published by Springer Science and Business Media LLC in The Esophagus
- Vol. 56 (4), 336-349
- https://doi.org/10.1007/s00535-021-01765-4
Abstract
Hepatitis viruses are chief pathogens of hepatitis and end-stage liver diseases. Their replication and related pathogenic process highly rely on the host micro-environment and multiple cellular elements, including exosomes. Representing with a sort of cell-derived vesicle structure, exosomes were considered to be dispensable cellular components, even wastes. Along with advancing investigation, a specific profile of exosome in driving hepatitis viruses’ infection and hepatic disease progression is revealed. Exosomes greatly affect the pathogenesis of hepatitis viruses by mediating their replication and modulating the host immune responses. The characteristics of host exosomes are markedly changed after infection with hepatitis viruses. Exosomes released from hepatitis virus-infected cells can carry viral nucleic or protein components, thereby acting as an effective subterfuge for hepatitis viruses by participating in viral transportation and immune escape. On the contrary, immune cell-derived exosomes contribute toward the innate antiviral immune defense and virus eradication. There is growing evidence supporting the application of exosomal biomarkers for predicting disease progress or therapeutic outcome, while exosomal nanoshuttles are regarded as promising therapeutic options based on their delivery properties and immune compatibility. In this review, we summarize the biogenesis and secretion mechanism of exosomes, review the recent findings pertaining to the role of exosomes in the interplay between hepatitis viruses and innate immune responses, and conclude their potential in further therapeutic application.Keywords
Funding Information
- Fundamental Research Funds for the Central Universities (ZYGX2020KYQD002)
- National Major Science and Technology Projects of China (2018ZX10715003)
- 1.3.5 Project for Disciplines of Excellence, West China Hospital, Sichuan University (ZYGD20009)
- 1.3.5 Project for Disciplines of Excellence, West China Hospital, Sichuan University (ZYJC18008)
This publication has 141 references indexed in Scilit:
- A liver‐specific microRNA binds to a highly conserved RNA sequence of hepatitis B virus and negatively regulates viral gene expression and replicationThe FASEB Journal, 2011
- Exosome Secretion Ameliorates Lysosomal Storage of Cholesterol in Niemann-Pick Type C DiseaseJournal of Biological Chemistry, 2010
- Inhibition of LINE-1 and Alu retrotransposition by exosomes encapsidating APOBEC3G and APOBEC3FVirology, 2010
- Plasmacytoid dendritic cells sense hepatitis C virus–infected cells, produce interferon, and inhibit infectionProceedings of the National Academy of Sciences of the United States of America, 2010
- Proteomics Analysis of A33 Immunoaffinity-purified Exosomes Released from the Human Colon Tumor Cell Line LIM1215 Reveals a Tissue-specific Protein SignatureMolecular & Cellular Proteomics, 2010
- Activation of Pattern Recognition Receptor-Mediated Innate Immunity Inhibits the Replication of Hepatitis B Virus in Human Hepatocyte-Derived CellsJournal of Virology, 2009
- Dendritic Cells Release HLA-B-Associated Transcript-3 Positive Exosomes to Regulate Natural Killer FunctionPLOS ONE, 2008
- Ceramide Triggers Budding of Exosome Vesicles into Multivesicular EndosomesScience, 2008
- Involvement of host cellular multivesicular body functions in hepatitis B virus buddingProceedings of the National Academy of Sciences of the United States of America, 2007
- Antitumor NK activation induced by the Toll-like receptor 3-TICAM-1 (TRIF) pathway in myeloid dendritic cellsProceedings of the National Academy of Sciences of the United States of America, 2007